US Patent Issued to Queen Mary University of London on July 14 for "Methods for predicting patient response to DMARDs" (British Inventors)

ALEXANDRIA, Va., July 14 -- United States Patent no. 12,681,015, issued on July 14, was assigned to Queen Mary University of London (London).

"Methods for predicting patient response to DMARDs" was invented by Jesmond Dalli (London), Romain Alexandre Colas (London), Costantino Pitzalis (London), Esteban Alberto Gomez Cifuentes (London) and Conrad Bessant (London).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present invention provides a method for predicting whether a patient having, suspected of having, or at risk of developing an inflammatory condition will respond to treatment with a disease-modifying antirheumatic drug (DMARD) comprising measuring the level of at least one specialized pro-resolving m...